Login / Signup

The risk of pulmonary adverse drug reactions of rebamipide and other drugs for acid-related diseases: An analysis of the national pharmacovigilance database in South Korea.

Bo Ram YangJae-Young LeeMyeong-Gyu Kim
Published in: Journal of digestive diseases (2022)
Rebamipide was less often reported for pulmonary AE. However, healthcare professionals need to be aware of the risk of pulmonary AE in elderly patients.
Keyphrases
  • adverse drug
  • pulmonary hypertension
  • drug induced
  • electronic health record
  • quality improvement